Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system.
Quarter Ended March 31, 2023
For Fiscal Year Ending Dec 31, 2022
Sign up today and receive company updates straight to your inbox.
Calyxt, Inc.
2800 Mount Ridge Road
Roseville, MN 55113
Argot Partners
Kimberly Minarovich
Cameron Willis
T: 212-600-1902
investors@calyxt.com
Broadridge Corporate Issuer Solutions, Inc.
1155 Long Island Avenue
Edgewood, NY 11717
T: 1-877-830-4932
https://www.broadridge-ir.com/resources/transfer-agent/default.aspx